🇺🇸 FDA
Pipeline program

Vitamine E-400 complex, Microgynon 30, 0,15 mg/0,03 mg omhulde tabletten

P19.040

Approved small_molecule active

Quick answer

Vitamine E-400 complex, Microgynon 30, 0,15 mg/0,03 mg omhulde tabletten for Migraine is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Migraine
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials